Winton Group LTD Gilead Sciences, Inc. Transaction History

Winton Group LTD

$1.35 Billion
Q1 2024

A detailed history of Winton Group LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Winton Group LTD holds 5,757 shares of GILD stock, worth $383,358. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,757

Holding current value

$383,358

% of portfolio

0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $412,086 - $502,528	5,757 New	5,757 $421,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $217,235 - $237,008	2,938 New	2,938 $220,000
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $364,130 - $414,856	-4,710 Reduced 65.53%	2,478 $205,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $2.47 Million - $3.55 Million	-39,629 Reduced 84.65%	7,188 $617,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $2.54 Million - $2.9 Million	-42,604 Reduced 47.64%	46,817 $2.89 Million

Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $2.77 Million - $3.12 Million	47,985 Added 115.81%	89,421 $5.53 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $569,585 - $713,751	9,834 Added 31.12%	41,436 $2.46 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $2.05 Million - $2.33 Million	31,602 New	31,602 $2.3 Million
Q1 2021 Jul 21, 2021	SELL	$60.0 - $68.46 $743,820 - $848,698	-12,397 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $2.98 Million - $3.4 Million	-52,631 Reduced 80.94%	12,397 $722,000
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $1.56 Million - $1.96 Million	-25,109 Reduced 27.86%	65,028 $4.11 Million
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $2.32 Million - $2.7 Million	32,089 Added 55.28%	90,137 $6.94 Million
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $3.64 Million - $4.66 Million	58,048 New	58,048 $4.34 Million
Q2 2019 Jul 08, 2019	SELL	$61.87 - $69.38 $210,667 - $236,238	-3,405 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $50,211 - $56,250	-803 Reduced 19.08%	3,405 $221,000
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $10,957 - $14,299	-181 Reduced 4.12%	4,208 $263,000
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $84,252 - $93,283	-1,182 Reduced 21.22%	4,389 $0
Q2 2018 Aug 20, 2018	SELL	$64.88 - $75.68 $136,442 - $159,155	-2,103 Reduced 27.4%	5,571 $0
Q1 2018 May 21, 2018	BUY	$72.84 - $88.8 $78,594 - $95,815	1,079 Added 16.36%	7,674 $0
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $600,221 - $704,574	-8,436 Reduced 56.12%	6,595 $472,000
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $11.7 Million - $13.8 Million	-161,648 Reduced 91.49%	15,031 $1.22 Million
Q2 2017 Aug 17, 2017	BUY	N/A	176,679	176,679 $12.5 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.16 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.64 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.63 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.08 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.84 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account